首页> 中文期刊> 《当代医学科学(英文)》 >P53 Regulation of Leukemia Cells with the Blockage of MDM2 by Antisense Oligonucleotides

P53 Regulation of Leukemia Cells with the Blockage of MDM2 by Antisense Oligonucleotides

         

摘要

The changes of expression and function of MDM2 and P53 by MDM2 specific antisense oligonucleotides were investigated in HL60 cells. Cells were divided into control group, AS group (MDM2 specific antisense oligonucleotides group), cisplatin group, and combined treatment group. FCM analysis and Western blot and RT-PCR were used to estimate apoptosis and the expression of MDM2 and P53. Our results showed that the transfection of MDM2 specific antisense oligonucleo- tides obviously inhibited MDM2 expression (P<0.01) and increased the expression of P53 (P<0.05). Apoptosis rate were reduced by MDM2 specific antisense oligonucletides and cisplatin (P<0.01). It is concluded that MDM2 specific antisense oligonucletides can inhibit the expression of MDM2, induce the expression of P53 and increase the apoptosis of leukemia cells after chemotherapy.

著录项

  • 来源
    《当代医学科学(英文)》 |2006年第4期|414-416|共3页
  • 作者单位

    Department of Internal Emergency;

    Tongji Hospital;

    Tongji Medical College;

    Huazhong University of Science and Technology;

    Wuhan 430030;

    China;

    Department of Chemotherapy and Radiation;

    Zhongnan Hospital;

    Wuhan University;

    Wuhan 430071;

    China;

    Department of Hematology;

    Tongji Hospital;

    Tongji Medical College;

    Huazhong University of Science and Technology;

    Wuhan 430030;

    China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 白血病;
  • 关键词

    白血病; 低聚核苷酸; 基因治疗; 肿瘤基因;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号